Premium
Is 3D Printing of Pharmaceuticals a Disruptor or Enabler?
Author(s) -
Liang Kun,
Brambilla Davide,
Leroux JeanChristophe
Publication year - 2019
Publication title -
advanced materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.707
H-Index - 527
eISSN - 1521-4095
pISSN - 0935-9648
DOI - 10.1002/adma.201805680
Subject(s) - enabling , pharmaceutical manufacturing , materials science , 3d printing , nanotechnology , scale (ratio) , pharmaceutical industry , biochemical engineering , process engineering , manufacturing engineering , risk analysis (engineering) , business , engineering , pharmacology , medicine , physics , composite material , quantum mechanics , psychiatry
Additive manufacturing (AM) is a fast‐growing manufacturing approach that comes with the promise of delivering personalized medicine to treat individual patients. However, large‐scale commercial applications in the pharmaceutical industry have been limited. Here, some of the challenges are discussed along with some pharmaceutical products where AM has the potential to make a tangible impact and pave the way for more rapid adoption are highlighted.